Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Blood

• Publication date

  2016-03-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2015-06-649970PMID 26675349PMCID PMC4778164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability

  2015cited by this paper
• Discovery of novel and selective SIRT6 inhibitors.

  2014cited by this paper
• RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS

  2014cited by this paper
• MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer

  2014cited by this paper
• Sirtuins in stress response: guardians of the genome

  2014cited by this paper
• Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism.

  2014cited by this paper
• Genome-wide kinase-chromatin interactions reveal the regulatory network of ERK signaling in human embryonic stem cells.

  2013cited by this paper
• Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics

  2013cited by this paper
• RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance

  2013cited by this paper
• DNA repair pathways in human multiple myeloma

  2013cited by this paper
• SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling.

  2013cited by this paper
• SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.

  2013cited by this paper
• The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

  2012cited by this paper
• Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

  2012cited by this paper
• The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun

  2012cited by this paper
• P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation

  2012cited by this paper
• Playing the end game: DNA double-strand break repair pathway choice.

  2012cited by this paper
• Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX

  2011cited by this paper
• SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

  2011cited by this paper
• SIRT6 Promotes DNA Repair Under Stress by Activating PARP1

  2011cited by this paper
• The dual role of sirtuins in cancer.

  2011cited by this paper
• Initial genome sequencing and analysis of multiple myeloma

  2011cited by this paper
• Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells.

  2011cited by this paper
• Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation

  2010cited by this paper
• The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.

  2010cited by this paper
• The DNA damage response: making it safe to play with knives.

  2010cited by this paper
• Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.

  2010cited by this paper
• SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span.

  2009cited by this paper
• The DNA-damage response in human biology and disease

  2009cited by this paper
• Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells

  2009cited by this paper
• Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair

  2009cited by this paper
• Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.

  2009cited by this paper
• The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability

  2009cited by this paper
• Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6

  2009cited by this paper
• Recent progress in the biology and physiology of sirtuins

  2009cited by this paper
• Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.

  2008cited by this paper
• Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

  2008cited by this paper
• SIRT6 in DNA repair, metabolism and ageing

  2008cited by this paper
• SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

  2008cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only.

  2007cited by this paper
• Network Analysis of Oncogenic Ras Activation in Cancer

  2007cited by this paper
• Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.

  2007cited by this paper
• Sirtuins: critical regulators at the crossroads between cancer and aging

  2007cited by this paper
• Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.

  2007cited by this paper
• Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

  2006cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Mouse Sir2 Homolog SIRT6 Is a Nuclear ADP-ribosyltransferase*

  2005cited by this paper
• Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.

  2005cited by this paper
• Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors*

  2004cited by this paper
• Genetic instabilities in human cancers

  1998cited by this paper

• SIRT6: From molecular functions to a potential therapeutic target in human disease

  2026cites this paper
• Integrative computational simulations and functional assays decode allosteric dysregulation in a pathogenic SIRT6 variant.

  2026cites this paper
• SIRT6 promotes intrahepatic cholangiocarcinoma development by reprogramming glutamine metabolism via enhanced GLUL

  2025cites this paper
• SIRT6 in health and diseases: from molecular mechanisms to therapeutic prospects.

  2025cites this paper
• Chlorogenic acid targets SIRT6 to relieve UVB - induced UV damage

  2025cites this paper
• The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia—A Promising Road Ahead

  2025cites this paper
• Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development

  2025cites this paper
• A new mechanism involved in cardiovascular senescence induced by environmentally relevant dose of 16 priority-controlled PAHs.

  2025cites this paper
• The role of acetylation and deacetylation in cancer metabolism

  2025cites this paper
• Análise da expressão e regulação biológica da proteína reguladora silenciadora 6 (SIRT6) no carcinoma espinocelular cutâneo

  2024cites this paper
• Sirtuins: Emergent Players in Tissue and Organ Regeneration

  2024cites this paper
• NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma

  2024cites this paper
• Targeting sirtuins for cancer therapy: epigenetics modifications and beyond

  2024cites this paper
• Discovery of Novel PROTAC SIRT6 Degraders with Potent Efficacy against Hepatocellular Carcinoma.

  2024cites this paper
• The ABA/LANCL1-2 Hormone/Receptors System Controls ROS Production in Cardiomyocytes through ERRα

  2024cites this paper
• Activation and inhibition of sirtuins: From bench to bedside

  2024cites this paper
• SIRT6 suppresses colon cancer growth by inducing apoptosis and autophagy through transcriptionally down-regulating Survivin.

  2024cites this paper
• The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma

  2024cites this paper
• SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs

  2024cites this paper
• Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma

  2024cites this paper
• Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

  2023cites this paper
• CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents

  2023cites this paper
• The Role of Sirtuin 6 in the Deacetylation of Histone Proteins as a Factor in the Progression of Neoplastic Disease

  2023cites this paper
• SIRT6 promotes metastasis and relapse in HER2-positive breast cancer

  2023cites this paper
• Myeloma and DNA damage.

  2023cites this paper
• MOF-mediated acetylation of SIRT6 disrupts SIRT6-FOXA2 interaction and represses SIRT6 tumor-suppressive function by upregulating ZEB2 in NSCLC.

  2023cites this paper
• Az idősödés során jellemző genetikai és epigenetikai változások és a gammopátiák progressziója •

  2023cites this paper
• SIRT6 ameliorates LPS-induced apoptosis and tight junction injury in ARDS through the ERK1/2 pathway and autophagy

  2023cites this paper
• Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability

  2022cites this paper
• Role of Sirtuins in the Pathobiology of Onco-Hematological Diseases: A PROSPERO-Registered Study and In Silico Analysis

  2022cites this paper
• Multiple Myeloma: Bioinformatic Analysis for Identification of Key Genes and Pathways

  2022cites this paper
• The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer

  2022cites this paper
• SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases

  2022cites this paper
• Mass spectrometry-based draft of the mouse proteome

  2022cites this paper
• Flavonoids as Sirtuin Modulators.

  2022cites this paper
• NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma

  2022cites this paper
• SIRT6 Widely Regulates Aging, Immunity, and Cancer

  2022cites this paper
• Multiple myeloma etiology and treatment

  2022cites this paper
• The sirtuin family in health and disease

  2022cites this paper
• Epigenetic regulation of radioresistance: insights from preclinical and clinical studies

  2022cites this paper
• Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment

  2022cites this paper
• The Role of Epigenetics in the Development and Progression of Multiple Myeloma

  2022cites this paper
• Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer.

  2022cites this paper
• Therapeutic Opportunities of Disrupting Genome Integrity in Adult Diffuse Glioma

  2022cites this paper
• Sirtuins in hematopoiesis and blood malignancies

  2021cites this paper
• Sirtuins, healthspan, and longevity in mammals

  2021cites this paper
• Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators

  2021cites this paper
• SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice

  2021cites this paper
• The Two-Faced Role of SIRT6 in Cancer

  2021influential citation
• SIRT6 in Senescence and Aging-Related Cardiovascular Diseases

  2021cites this paper
• SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma.

  2021cites this paper
• Silencing Sirtuin5 induces DNA damage by suppressing the pentose phosphate pathway in a demalonylation-dependent manner: A possible target for anticancer therapy in CRC

  2021cites this paper
• Sirtuin signaling in hematologic malignancies

  2021cites this paper
• SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non‐Small cell lung cancer and inhibit tumor progression

  2021cites this paper
• LANCL1 binds abscisic acid and stimulates glucose transport and mitochondrial respiration in muscle cells via the AMPK/PGC-1α/Sirt1 pathway

  2021cites this paper
• Emerging Therapeutic Potential of SIRT6 Modulators

  2021cites this paper
• RBM5-AS1 promotes radioresistance in medulloblastoma through stabilization of SIRT6 protein

  2021cites this paper
• CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway

  2021cites this paper
• Histone Deacetylase Inhibitors

  2021cites this paper
• Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy

  2021cites this paper
• Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

  2021cites this paper
• Resveratrol blocks retrotransposition of LINE-1 through PPAR α and sirtuin-6

  2021cites this paper
• One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies

  2021cites this paper
• Emerging roles of SIRT6 in human diseases and its modulators

  2020cites this paper
• A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

  2020cites this paper
• Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma

  2020cites this paper
• SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation

  2020cites this paper
• Hepatic SIRT6 deficit promotes liver tumorigenesis in the mice models

  2020cites this paper
• Long intergenic noncoding RNA smad7 (Linc‐smad7) promotes the epithelial‐mesenchymal transition of HCC by targeting the miR‑125b/SIRT6 axis

  2020cites this paper
• Author Correction: Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia

  2020cites this paper
• Discovery of Potent Small Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-pancreatic Ductal Adenocarcinoma Activity.

  2020cites this paper
• Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling

  2020cites this paper
• Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia

  2020cites this paper
• Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators

  2020cites this paper
• Genomic Instability in Multiple Myeloma.

  2020cites this paper
• Sirt6 in pro-opiomelanocortin neurons controls energy metabolism by modulating leptin signaling

  2020cites this paper
• Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma.

  2020cites this paper
• SIRT2 protects peripheral neurons from cisplatin-induced injury by enhancing nucleotide excision repair.

  2020cites this paper
• Using mass spectrometry to quantify changes in histone post-translational modifications as a result of DNA double-strand breaks

  2019cites this paper
• Genomic instability in Multiple Myeloma-relevance for Clinical Outcome and Efficacy of Therapy

  2019cites this paper
• Granulosa-Lutein Cell Sirtuin Gene Expression Profiles Differ between Normal Donors and Infertile Women

  2019cites this paper
• NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma

  2019cites this paper
• SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors α

  2019cites this paper
• Aberrant Epigenomic Regulatory Networks in Multiple Myeloma and Strategies for Their Targeted Reversal

  2019cites this paper
• Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin

  2019cites this paper
• SIRT6, a Mammalian deacylase with multitasking abilities.

  2019cites this paper
• Epigenetic Drug Discovery for Cancer

  2019cites this paper
• Current role of mammalian sirtuins in DNA repair.

  2019cites this paper
• The sirtuin family in cancer

  2019cites this paper
• Germline Risk Contribution to Genomic Instability in Multiple Myeloma

  2019cites this paper
• Targeting transcription factors in multiple myeloma: evolving therapeutic strategies

  2019cites this paper
• The signaling pathways that mediate the anti-cancer effects of caloric restriction.

  2019cites this paper
• The role of SIRT6 in tumors

  2018influential citation
• Commentary: Antidepressive effects of targeting ELK-1 signal transduction

  2018cites this paper
• Evidence for excessive osteoclast activation in SIRT6 null mice

  2018cites this paper
• Activating the Anaphase Promoting Complex to Enhance Genomic Stability and Prolong Lifespan

  2018cites this paper
• A Review of the Recent Advances Made with SIRT6 and its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets

  2018cites this paper
• The biological significance of histone modifiers in multiple myeloma: clinical applications

  2018cites this paper
• Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling.

  2018cites this paper
• SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.

  2018cites this paper